Liu JF
No ORCID on file
· 3 papers in corpus
· active 2019-2024
Study types
- meta-analysis 1
- other 1
Condition tags
- endometriosis 2
- dysmenorrhea 1
- chronic_pelvic_pain 1
- dyspareunia 1
Top journals
Frequent coauthors
- En Chang 2
- Jin-Feng Liu 2
- Wei Wei 2
- Chang E 2
- Hyman DM 1
- Hou Y 1
- Cangemi NA 1
- Li Zhong 1
- Leng YE 1
- Haqq CM 1
other
2024
OBJECTIVE: Elagolix is approved for the treatment of moderate-to-severe pain associated with endometriosis. However, the long-term safety of elagolix in a large sample of real-world patients is unknown. METHODS: The U.S. Food and Drug Admi…
meta-analysis
2024
BACKGROUND: Elagolix, an approved non-peptide GnRH antagonist, shows promise in relieving endometriosis-related pain, but its short- and mid-term efficacy and potential side effects are still under investigation. OBJECTIVE: The aim is to p…
2019
PurposeSTM 434 is a soluble receptor ligand trap targeting activin A, a protein in the TGFβ family that plays important roles in growth, differentiation, and cancer cachexia. This study evaluated the safety, antitumor activity, and metaboli…